Teleflex

TFX · NYSE

$131.15+$1.47 (+1.13%)TodayMarket closed · Oct 20, 7:00 PM ET

Prev close $129.68

Latest news

Press releaseOct 12, 6:30 AM ETBusiness Wire
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
NewsOct 8, 4:14 AM ET
Full Transcript: Teleflex Q2 2026 Earnings Call
Press releaseSep 29, 6:30 AM ETBusiness Wire
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
NewsSep 28, 1:03 PM ETPiero Cingari
Nasdaq 100 Sinks, Oil Rallies as Trump Rejects Iran's Hormuz Plan: Stock Market Today
Press releaseSep 8, 6:30 AM ETBusiness Wire
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
Press releaseSep 4, 6:30 AM ETBusiness Wire
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
Press releaseAug 6, 6:45 AM ETBusiness Wire
Teleflex Announces Quarterly Dividend
NewsAug 6, 6:36 AM ET
Teleflex Q2 Adj. EPS $1.76 Beats $1.28 Estimate, Sales $570.332M Beat $559.596M Estimate
Press releaseAug 6, 6:30 AM ETBusiness Wire
Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook
Press releaseAug 3, 4:15 PM ETBusiness Wire
Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion
Press releaseJul 29, 4:15 PM ETBusiness Wire
Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma
NewsJul 29, 1:29 PM ET
U.S. FDA Licenses First Freeze-dried Plasma Product Ezplaz In The United States; Ezplaz Available In Group Ab And Group A Low-Titer Anti-B For Emergency Transfusion
Press releaseJul 23, 6:30 AM ETBusiness Wire
Teleflex Announces Second Quarter 2026 Earnings Conference Call Information
Press releaseJul 21, 8:44 AM ETBusiness Wire
Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.
Press releaseJul 7, 6:30 AM ETBusiness Wire
Teleflex Publishes 2025 Global Impact Report
NewsJun 23, 6:34 AM ET
Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold
Press releaseJun 23, 6:30 AM ETBusiness Wire
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold
Press releaseJun 9, 6:30 AM ETBusiness Wire
Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)
Press releaseJun 1, 5:40 PM ETBusiness Wire
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering
Press releaseJun 1, 7:45 AM ETBusiness Wire
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032
Press releaseMay 21, 6:30 AM ETBusiness Wire
Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer
Press releaseMay 15, 4:30 PM ETBusiness Wire
Teleflex Announces Quarterly Dividend
NewsMay 7, 6:32 AM ET
Teleflex Q1 Adj. EPS $1.39 Beats $1.21 Estimate, Sales $548.300M Beat $533.339M Estimate
Press releaseMay 7, 6:30 AM ETBusiness Wire
Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook
Press releaseApr 30, 6:30 AM ETBusiness Wire
Teleflex Appoints Jason Weidman as President and CEO
Press releaseApr 23, 6:30 AM ETBusiness Wire
Teleflex Announces First Quarter 2026 Earnings Conference Call Information
NewsApr 22, 1:57 PM ETPiero Cingari
Nasdaq 100 Tops Records As Iran Ceasefire Extends, GE Vernova Soars 13%: Stock Market Today
NewsApr 22, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsApr 22, 3:34 AM ET
'CVC, GTCR Weigh Take-Private Of Medical Equipment Provider Teleflex' - Bloomberg
Press releaseApr 9, 6:30 AM ETBusiness Wire
Teleflex Announces Governance Updates
Press releaseMar 27, 2:31 PM ETBusiness Wire
Irenic Comments on Teleflex's Announcement That It Is Open to Strategic Alternatives
Press releaseMar 27, 12:57 PM ETBusiness Wire
Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution
Press releaseMar 27, 7:30 AM ETBusiness Wire
Irenic Sends Letter to Teleflex Board of Directors Regarding Its Refusal to Engage with Potential Acquirors
NewsMar 17, 4:50 PM ET
Teleflex Says On March 11, Co, Acute Care And Urology Purchaser Received Request For Additional Information & Documentary Material From U.S. FTC; Acute Care And Urology Deal Anticipated To Be Completed In Second Half Of 2026
Press releaseMar 12, 8:02 AM ETBusiness Wire
o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning
NewsFeb 26, 7:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseFeb 26, 6:30 AM ETBusiness Wire
Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook
NewsFeb 25, 12:03 PM ET
A Glimpse of Teleflex's Earnings Potential
NewsJan 8, 12:19 PM ETPiero Cingari
Defense Stocks Rally As Trump Pledges $1.5T Military Budget: What's Moving Markets Thursday?
Press releaseDec 9, 9:20 AM ETBusiness Wire
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
Press releaseDec 9, 9:04 AM ETGlobe Newswire
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
Press releaseNov 6, 6:30 AM ETGlobe Newswire
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
Press releaseJul 31, 6:30 AM ETGlobe Newswire
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
Press releaseMay 1, 6:30 AM ETGlobe Newswire
Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook
Press releaseFeb 27, 6:39 AM ETGlobe Newswire
Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results
Press releaseFeb 27, 6:33 AM ETGlobe Newswire
Teleflex Announces Intent to Separate into Two Publicly Traded Companies

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold

Full Transcript: Teleflex Q2 2026 Earnings Call

Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology

Nasdaq 100 Sinks, Oil Rallies as Trump Rejects Iran's Hormuz Plan: Stock Market Today

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

Teleflex Announces Quarterly Dividend

Teleflex Q2 Adj. EPS $1.76 Beats $1.28 Estimate, Sales $570.332M Beat $559.596M Estimate

Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion

Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma

U.S. FDA Licenses First Freeze-dried Plasma Product Ezplaz In The United States; Ezplaz Available In Group Ab And Group A Low-Titer Anti-B For Emergency Transfusion

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Publishes 2025 Global Impact Report

Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold

Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Announces Quarterly Dividend

Teleflex Q1 Adj. EPS $1.39 Beats $1.21 Estimate, Sales $548.300M Beat $533.339M Estimate

Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

Teleflex Appoints Jason Weidman as President and CEO

Teleflex Announces First Quarter 2026 Earnings Conference Call Information

Nasdaq 100 Tops Records As Iran Ceasefire Extends, GE Vernova Soars 13%: Stock Market Today

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

'CVC, GTCR Weigh Take-Private Of Medical Equipment Provider Teleflex' - Bloomberg

Teleflex Announces Governance Updates

Irenic Comments on Teleflex's Announcement That It Is Open to Strategic Alternatives

Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution

Irenic Sends Letter to Teleflex Board of Directors Regarding Its Refusal to Engage with Potential Acquirors

Teleflex Says On March 11, Co, Acute Care And Urology Purchaser Received Request For Additional Information & Documentary Material From U.S. FTC; Acute Care And Urology Deal Anticipated To Be Completed In Second Half Of 2026

o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

A Glimpse of Teleflex's Earnings Potential

Defense Stocks Rally As Trump Pledges $1.5T Military Budget: What's Moving Markets Thursday?

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook

Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results

Teleflex Announces Intent to Separate into Two Publicly Traded Companies